How GLP-1 Medications Are Driving Economic Growth — and Gym Membership Demand
- Karisa Gilmer
- Dec 29, 2025
- 1 min read
GLP-1 medications aren’t just a health breakthrough — they’re an economic one.
Goldman Sachs estimates that widespread GLP-1 adoption could increase U.S. GDP by up to 1% by improving workforce participation and productivity. Obesity currently reduces economic output through missed work, lower performance, and chronic illness.

Healthier people:
Work more
Earn more
Spend more on fitness, wellness, and longevity
That matters for gym owners.
As GLP-1 users regain energy and confidence, they are more likely to:
Join gyms
Hire personal trainers
Invest in strength and conditioning
Commit to long-term memberships
This trend expands the total addressable market for gyms, especially those positioned as health partners rather than just workout facilities.
GLP-1s are increasing the number of people who can succeed in gyms.
Capture this growing market instead of competing against it.
👉 Apply to become a YourFitPrint Gym Partner and access GLP-1–ready education, branding, and member resources.




Comments